US Patent 9879022 Bicyclic-fused heteroaryl or aryl compounds
Patent 9879022 was granted and assigned to Pfizer Limited on January, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+161 characters)
Article
Patent abstract
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia,
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09879022 Bicyclic-fused heteroaryl or aryl compounds US Patent 9879022 Bicyclic-fused heteroaryl or aryl compounds
Infobox
Patent Number
0987902200
Patent Number
987902200
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
098790220
Date of Patent
January 30, 2018
0Patent Application Number
152328920
Date Filed
August 10, 2016
0Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
098790220
Date of Patent
January 30, 2018
0Patent Application Number
152328920
Date Filed
August 10, 2016
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09879022 Bicyclic-fused heteroaryl or aryl compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09879022
Date of patent
January 30, 2018
Patent application number
15232892
Date Filed
August 10, 2016
Patent primary examiner
Find more entities like US Patent 9879022 Bicyclic-fused heteroaryl or aryl compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
